secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2022-02-01T23:59:59+00:00
Accession:  0001437749-22-002038
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne Q2 FY2022: GAAP EPS $1.94, adj EPS $1.88; rev $269.3M; $0.32 dividend, $400M buyback
--------------------------------------------------------------------------------

- Organic revenue +17% to $269.3M; Protein Sciences organic growth 19% with ProteinSimple up 27% and GMP Proteins >180%.
- GAAP EPS $1.94 vs $1.15 YoY; record adjusted EPS $1.88 vs $1.62 YoY.
- Adjusted operating income $102.8M, margin 38.3%; up 18% YoY.
- Board declared $0.32 quarterly dividend, payable Feb 25, 2022 to holders of record Feb 11, 2022.
- New $400M share repurchase program approved, replacing prior program, effective Feb 2, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000143774922002038/0001437749-22-002038-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000143774922002038/tech20220131_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-002038

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer